These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18680758)

  • 1. Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties.
    Weissman BA; Raveh L
    Toxicol Appl Pharmacol; 2008 Oct; 232(2):351-8. PubMed ID: 18680758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional drugs as novel antidotes for organophosphates' poisoning.
    Weissman BA; Raveh L
    Toxicology; 2011 Dec; 290(2-3):149-55. PubMed ID: 21978866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning.
    Raveh L; Chapman S; Cohen G; Alkalay D; Gilat E; Rabinovitz I; Weissman BA
    Neurotoxicology; 1999 Aug; 20(4):551-9. PubMed ID: 10499354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caramiphen edisylate: an optimal antidote against organophosphate poisoning.
    Raveh L; Eisenkraft A; Weissman BA
    Toxicology; 2014 Nov; 325():115-24. PubMed ID: 25201353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
    Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
    Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction.
    Raveh L; Brandeis R; Gilat E; Cohen G; Alkalay D; Rabinovitz I; Sonego H; Weissman BA
    Toxicol Sci; 2003 Sep; 75(1):108-16. PubMed ID: 12832655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties (Toxicol. Appl. Pharmacol. 232, 351-358, 2008).
    Dorandeu F; Carpentier P; Dhote F; Mion G; Baille V; Testylier G; Lallement G
    Toxicol Appl Pharmacol; 2009 Jul; 238(2):188; author reply 189. PubMed ID: 19445958
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman.
    Lallement G; Baubichon D; Clarençon D; Galonnier M; Peoc'h M; Carpentier P
    Neurotoxicology; 1999 Aug; 20(4):675-84. PubMed ID: 10499365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
    Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
    Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen.
    Raveh L; Rabinovitz I; Gilat E; Egoz I; Kapon J; Stavitsky Z; Weissman BA; Brandeis R
    Toxicol Appl Pharmacol; 2008 Feb; 227(1):155-62. PubMed ID: 18320638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction.
    Raveh L; Weissman BA; Cohen G; Alkalay D; Rabinovitz I; Sonego H; Brandeis R
    Neurotoxicology; 2002 May; 23(1):7-17. PubMed ID: 12164550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New therapeutic options in Alzheimer's disease].
    García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
    Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats.
    Schultz MK; Wright LK; de Araujo Furtado M; Stone MF; Moffett MC; Kelley NR; Bourne AR; Lumeh WZ; Schultz CR; Schwartz JE; Lumley LA
    Neurotoxicol Teratol; 2014; 44():89-104. PubMed ID: 24946037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies.
    Chen Y
    Neurotoxicology; 2012 Jun; 33(3):391-400. PubMed ID: 22498093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant efficacy of drugs with cholinergic and/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman.
    Myhrer T; Enger S; Aas P
    Neurochem Res; 2008 Feb; 33(2):348-54. PubMed ID: 17710542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats.
    Myhrer T; Enger S; Aas P
    Pharmacol Biochem Behav; 2008 Jun; 89(4):633-8. PubMed ID: 18384867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of organophosphate-induced seizures.
    Lallement G; Dorandeu F; Filliat P; Carpentier P; Baille V; Blanchet G
    J Physiol Paris; 1998; 92(5-6):369-73. PubMed ID: 9789839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
    Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
    Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs.
    Dorandeu F; Baille V; Mikler J; Testylier G; Lallement G; Sawyer T; Carpentier P
    Toxicology; 2007 May; 234(3):185-93. PubMed ID: 17408839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential pharmacological strategies for the improved treatment of organophosphate-induced neurotoxicity.
    Kaur S; Singh S; Chahal KS; Prakash A
    Can J Physiol Pharmacol; 2014 Nov; 92(11):893-911. PubMed ID: 25348489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.